Quick Answer
NANOVIRICIDES, INC. reported Net Income Loss of -$9.47 million for the year ending 2025.
- NANOVIRICIDES, INC. showed a decrease of -14.1% in Net Income Loss from 2024 to 2025.
- This data is from NANOVIRICIDES, INC.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: -$6.27 million | Q4 2013: -$1.69 million | Q1 2014: $1.32 million | Q3 2014: $851.7 thousand | Q4 2014: -$1.88 million | Q1 2015: -$251.0 thousand | Q3 2015: -$1.31 million | Q4 2015: -$2.78 million | Q1 2016: -$4.99 million | Q3 2016: -$3.06 million | Q4 2016: -$1.55 million | Q1 2017: -$3.14 million | Q3 2017: -$2.01 million | Q4 2017: -$2.80 million | Q1 2018: -$2.11 million | Q3 2018: -$1.84 million | Q4 2018: -$2.23 million | Q1 2019: -$2.14 million | Q3 2019: -$1.56 million | Q4 2019: -$1.93 million | Q1 2020: -$8.08 million | Q3 2020: -$2.31 million | Q4 2020: -$2.33 million | Q1 2021: -$2.11 million | Q3 2021: -$2.61 million | Q4 2021: -$1.92 million | Q1 2022: -$1.79 million | Q3 2022: -$1.57 million | Q4 2022: -$1.75 million | Q1 2023: -$1.70 million | Q3 2023: -$1.97 million | Q4 2023: -$2.11 million | Q1 2024: -$1.85 million | Q3 2024: -$3.13 million | Q4 2024: -$2.03 million | Q1 2025: -$2.22 million | Q3 2025: -$1.79 million | Q4 2025: -$2.22 million.
- Over the full 13 years of available data (2013 to 2025), NANOVIRICIDES, INC.'s Net Income Loss has declined by 6.7%.
- Historical annual values: Fiscal year 2025: -$9.47 million | Fiscal year 2024: -$8.29 million | Fiscal year 2023: -$8.59 million | Fiscal year 2022: -$8.11 million | Fiscal year 2021: -$8.82 million | Fiscal year 2020: -$13.45 million | Fiscal year 2019: -$8.42 million | Fiscal year 2018: -$8.56 million | Fiscal year 2017: -$10.30 million | Fiscal year 2016: -$10.72 million | Fiscal year 2015: -$2.20 million | Fiscal year 2014: -$13.60 million | Fiscal year 2013: -$8.88 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: